AI Chat
Macro & News
Stocks
Alpha Lab
Utility
Menu
My Activity
EN
Login
EN
Surge Analysis
/
Eterna Therapeutics Inc.
/
2026-05-12
▲ SURGE
Eterna Therapeutics Inc.
+66.6%
ERNA
NASDAQ
Healthcare
2026-05-12
12.01
Close
7.21
Prev Close
+66.57%
Change
39.3x
Vol Ratio
Why It Surged
No related news available.
Related News
Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an Oral, Once-Daily KIT Inhibitor, in Development for the Treatment of Urticaria
Weeklyvoice
2026-04-13
Neumora lines up April 13 Needham healthcare conference webcast
Stocktitan
2026-04-06
Neumora Therapeutics to Participate in 25th Annual Needham Virtu
Gurufocus
2026-04-06
NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine Application
Weeklyvoice
2026-04-06
Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular ...
Postregister
2026-04-16
Technical Analysis
Signals
BB Upper Break
Overbought
MACD Bullish
Above SMA20
Key Indicators
81.18
RSI (14)
5.45
SMA 20
1.57
Bollinger Lower
9.34
Bollinger Upper
5.45
Bollinger Mid
0.77
MACD
0.06
MACD Signal
0.70
MACD Hist
View Company
Back to Surge Stocks
Home
Chat
Portfolio
Activity
Menu
Eterna Therapeutics Inc. Surged +66.6% on 2026-05-12 — Analysis | Alpha Lenz